direct to your inboxNHS coronavirus patients are to receive new life-saving treatment which can reduce hospital stay by up to 10 days, the government has announced,Patients across the UK who are admitted to intensive care units due to Covid-19 will receive drugs which are typically used to treat rheumatoid arthritis.The REMAP-CAP clinical trial, funded by the government, found tocilizumab and sarilumab reduced the relative risk of death by 24 percent when administered to patients within 24 hours